Because of the problem to evaluate biological
activity in water‑soluble substances in
all phases
Liu, Kang,
Wong, Chris Ho-Ming,
Zhao, Hongda,
Ng, Chi Fai,
Teoh, Jeremy Yuen-Chun,
Laguna, Pilar (2025) .66). Conclusions and clinical implications: Anticoagulant and
antiaggregant therapy in patients undergoing RNU